Coronavirus Update:What patients and families need to know
The Children's National Research Institute
Learn more about the Locked Nucleic Acid Gapmers (LNA Gapmers) that were developed by Children's National researchers to treat facioscapulohumeral muscular dystrophy (FSHD).
Discover how researchers developed a strategy of targeting microRNAs (miRNAs) to treat muscular dystrophies and other inflammatory disorders.
Read about how researchers developed theranostic agents that combine several applications of multimodal imaging, diagnosing and delivering of therapeutic compositions all within a single platform.